Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1



Status:Archived
Conditions:HIV / AIDS
Therapuetic Areas:Immunology / Infectious Diseases
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:May 2010
End Date:December 2011

Use our guide to learn which trials are right for you!

Maraviroc Plus Darunavir/Ritonavir Study for Treatment-Naïve Patients Infected With R5-tropic HIV-1 Based on Enhanced Sensitivity Trofile


The objective of this study is to evaluate the safety and efficacy of a novel combination
antiretroviral therapy regimen consisting of maraviroc plus darunavir/ritonavir in
treatment-naive patients infected with R5-tropic HIV-1. The hypothesis is that in
treatment-naive subjects infected with R5-tropic HIV-1, combination antiretroviral therapy
with maraviroc plus darunavir/ritonavir is well tolerated and efficacious.



We found this trial at
5
sites
?
mi
from
Omaha, NE
Click here to add this to my saved trials
201 East Huron Street
Chicago, Illinois 60611
(847) 491-3741
Northwestern University Northwestern is recognized both nationally and internationally for the quality of its educational...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chicago, Illinois 60612
?
mi
from
Chicago, IL
Click here to add this to my saved trials
1400 NW 12th Ave
Miami, Florida 33136
(305) 689-5511
University of Miami Hospital The University of Miami changed the face of modern health care...
?
mi
from
Miami, FL
Click here to add this to my saved trials
San Francisco, California 94115
?
mi
from
San Francisco, CA
Click here to add this to my saved trials